A new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears to have fewer side effects than a previous therapy.
View some of the top videos produced this year to highlight CUMC research and education news.
Among this year's highlights are a building topping-off, a White House collaboration, connections made through art, and a research project with implications for campuses at Columbia and beyond.
P&S researcher Dritan Agalliu, PhD, finds pathway by which recurrent strep infections may lead to autoimmune psychiatric disorders.
Review some of the year's top stories about research at Columbia University Medical Center's four schools.
P&S researcher, Donna Farber, PhD, discovers fundamental characteristics of infant immune system and development.
Mailman professor Dale Hesdorffer examines association between epilepsy and suicidal behavior, strengthening evidence of an underlying commonality.
CUMC lost several faculty members in 2015. Read more about their lives.
CUMC students organized events this fall that focused on health care reform, human rights, and new health care technology.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.